These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23883485)

  • 21. The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
    Soraoka H; Oniki K; Matsuda K; Ono T; Taharazako K; Uchiyashiki Y; Kamihashi R; Kita A; Takashima A; Nakagawa K; Yasui-Furukori N; Kadowaki D; Miyata K; Saruwatari J
    Biol Pharm Bull; 2016; 39(9):1468-74. PubMed ID: 27582327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
    Kung FC; Ishii R; Liu HC; Takeda M
    Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells.
    Mizoguchi K; Ikarashi Y
    Front Pharmacol; 2017; 8():655. PubMed ID: 28979206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advance in studies on neuroprotective mechanism of Uncariae Ramulus Cum Uncis].
    Wei FF; Zeng CQ; Zhao YH; Liu L
    Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(14):2603-7. PubMed ID: 25272481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical profiling with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia.
    Niu Y; Li F; Inada C; Tanaka K; Watanabe S; Fujiwara H; Sasaki-Hamada S; Oka J; Matsumoto K
    J Pharm Biomed Anal; 2015 Feb; 104():21-30. PubMed ID: 25459756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan.
    Nishi A; Yamaguchi T; Sekiguchi K; Imamura S; Tabuchi M; Kanno H; Nakai Y; Hashimoto K; Ikarashi Y; Kase Y
    Neuroscience; 2012 Apr; 207():124-36. PubMed ID: 22314317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of aging on chondroitin sulfate proteoglycan expression and neural stem/progenitor cells in rat brain and improving effects of a herbal medicine, yokukansan.
    Tanaka Y; Mizoguchi K
    Neuroscience; 2009 Dec; 164(3):1224-34. PubMed ID: 19729050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the benzodiazepine system in the anxiolytic-like effect of Yokukansan (Yi-gan san).
    Kamei J; Miyata S; Ohsawa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1431-7. PubMed ID: 19647028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yokukansankachimpihange, a traditional Japanese (Kampo) medicine, enhances the adaptation to circadian rhythm disruption by increasing endogenous melatonin levels.
    Imamura S; Tabuchi M; Oizumi H; Ueki T; Omiya Y; Ikarashi Y; Mizoguchi K
    J Pharmacol Sci; 2020 Nov; 144(3):129-138. PubMed ID: 32921394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis.
    Hyde AJ; May BH; Dong L; Feng M; Liu S; Guo X; Zhang AL; Lu C; Xue CC
    J Psychopharmacol; 2017 Feb; 31(2):169-183. PubMed ID: 27899689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells.
    Terawaki K; Ikarashi Y; Sekiguchi K; Nakai Y; Kase Y
    J Ethnopharmacol; 2010 Feb; 127(2):306-12. PubMed ID: 19913081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.
    Ueki T; Mizoguchi K; Yamaguchi T; Nishi A; Sekiguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2015 May; 166():23-30. PubMed ID: 25732836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein.
    Matsumoto T; Kaifuchi N; Mizuhara Y; Warabi E; Watanabe J
    J Nat Med; 2018 Sep; 72(4):897-904. PubMed ID: 29797179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
    Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
    Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential usefulness of the kampo medicine yokukansan, containing uncaria hook, for paediatric emotional and behavioural disorders: a case series.
    Tanaka Y; Sakiyama T
    Evid Based Complement Alternat Med; 2013; 2013():502726. PubMed ID: 24204394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.
    Sasaki-Hamada S; Suzuki A; Ueda Y; Matsumoto K; Oka JI
    J Pharmacol Sci; 2017 Feb; 133(2):110-113. PubMed ID: 28233634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: A case report.
    Akiyama H; Hasegawa Y
    Medicine (Baltimore); 2019 Sep; 98(36):e17000. PubMed ID: 31490382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.